4-Fluoro-2-Methoxybenzeneboronic acid pinacol ester, 96%
- ₹12865 - ₹38441
- Product name: 4-Fluoro-2-Methoxybenzeneboronic acid pinacol ester, 96%
- CAS: 624741-83-9
- MF: C13H18BFO3
- MW: 252.09
- EINECS:
- MDL Number:MFCD18732613
- Synonyms:4-Fluoro-2-Methoxybenzeneboronic acid pinacol ester, 96%;4-Fluoro-2-methoxyphenylboronic acid pinacol ester;2-(4-fluoro-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 2-(4-fluoro-2-methoxyphenyl)-4,4,5,5-tetramethyl-
2 prices
Selected condition:
Brand
- ALFA India
Package
- 250mg
- 1g
- ManufacturerALFA India
- Product numberALF-H62391-MD
- Product description4-Fluoro-2-methoxybenzeneboronic acid pinacol ester, 96%
- Packaging250mg
- Price₹12865
- Updated2022-05-26
- Buy
- ManufacturerALFA India
- Product numberALF-H62391-03
- Product description4-Fluoro-2-methoxybenzeneboronic acid pinacol ester, 96%
- Packaging1g
- Price₹38441
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ALFA India | ALF-H62391-MD | 4-Fluoro-2-methoxybenzeneboronic acid pinacol ester, 96% | 250mg | ₹12865 | 2022-05-26 | Buy |
ALFA India | ALF-H62391-03 | 4-Fluoro-2-methoxybenzeneboronic acid pinacol ester, 96% | 1g | ₹38441 | 2022-05-26 | Buy |
Properties
Boiling point :315.1±32.0 °C(Predicted)
Density :1.08±0.1 g/cm3(Predicted)
form :Solid
Density :1.08±0.1 g/cm3(Predicted)
form :Solid
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Suppliers and manufacturers
Alfa Aesar
Neostar United (Changzhou) Industrial Co., Ltd.
Allfluoro pharmaceutical co. ltd.
Hefei TNJ Chemical Industry Co.,Ltd.
Coresyn Pharmatech Co., Ltd.
Aceschem Inc.
Shaoxin Catsyn Co., Ltd.
Shandong Xiya Chemical Co., Ltd.
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Lianhe Aigen Pharmatech Co.,Ltd.